Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives may cause hair loss in women.

Lecithin-based microparticles can deliver minoxidil for hair growth effectively with less skin irritation.

Finasteride niosomes were developed and found to be effective in treating hair loss, with better results than commercial minoxidil, and could be a promising topical treatment for hair loss.

Niosomes improve minoxidil skin delivery for hair loss treatment.

Using a patient's own fat tissue helped treat hair loss caused by an injury.

Hair loss is caused by genetics and hormones, diagnosed through examination and biopsy, and treated with medications or surgery.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

The article helps identify common, non-harmful skin conditions in newborns to avoid undue concern and treatment.

Dr. Shoji Okuda's early hair transplantation techniques were rediscovered after being overlooked due to World War II.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

The skin is the largest organ, protecting the body, regulating temperature, and producing hormones.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

The document concludes that "hot comb alopecia" is now called "central cicatricial centrifugal alopecia" and its causes are complex.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Hair loss in women may have causes other than hormones.

Hair loss in women not always linked to increased oil production; other factors may be involved.